Novartis Wins Judgment In Mylan Heart Drug Patent Fight

By Adam Lidgett · July 7, 2023, 1:45 PM EDT

A West Virginia federal judge said Mylan's proposed generic version of heart medication Entresto would infringe a pair of patents that Swiss pharmaceutical giant Novartis has on the brand-name product....

To view the full article, register now.